The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model

Abstract

These findings provide new mechanistic insights into the collateral activity of RfxCas13d in mammalian cells and warn that the biosafety of the CRISPR-Cas13 system needs further evaluation before application to clinical treatments.